AstraZeneca Pharma India (BOM:506820) Ending Cash Position : ₹0 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is AstraZeneca Pharma India Ending Cash Position?

AstraZeneca Pharma India's Ending Cash Position for the quarter that ended in Mar. 2024 was ₹0 Mil.

AstraZeneca Pharma India's annual Ending Cash Position increased from Mar. 2022 (₹4,484 Mil) to Mar. 2023 (₹5,003 Mil) and increased from Mar. 2023 (₹5,003 Mil) to Mar. 2024 (₹5,056 Mil).

AstraZeneca Pharma India Ending Cash Position Historical Data

The historical data trend for AstraZeneca Pharma India's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Pharma India Ending Cash Position Chart

AstraZeneca Pharma India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Ending Cash Position

Get a 7-Day Free Trial

835.00

3,523.40

4,484.20

5,003.37

5,055.69

AstraZeneca Pharma India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

AstraZeneca Pharma India Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

AstraZeneca Pharma India's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	5003.374	+	52.313
	=	5,056

AstraZeneca Pharma India's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0

AstraZeneca Pharma India Ending Cash Position Related Terms

Thank you for viewing the detailed overview of AstraZeneca Pharma India's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca Pharma India (BOM:506820) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca Pharma India Ltd (BOM:506820) » Definitions » Ending Cash Position

Traded in Other Exchanges

ASTRAZEN:India

Address

Outer Ring Road, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Bangalore, KA, IND, 560 045

Website

https://www.astrazeneca.com

AstraZeneca Pharma India Ltd is engaged in the manufacture, distribution, and marketing of pharmaceutical products. Its only operating segment being Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation and Autoimmunity, Neuroscience and Infection and Vaccines.

AstraZeneca Pharma India (BOM:506820) Headlines

No Headlines